140 related articles for article (PubMed ID: 17763059)
21. Gelatin microspheres crosslinked with D,L-glyceraldehyde as a potential drug delivery system: preparation, characterisation, in vitro and in vivo studies.
Vandelli MA; Rivasi F; Guerra P; Forni F; Arletti R
Int J Pharm; 2001 Mar; 215(1-2):175-84. PubMed ID: 11250103
[TBL] [Abstract][Full Text] [Related]
22. Biocompatibility of chemically cross-linked gelatin hydrogels for ophthalmic use.
Lai JY
J Mater Sci Mater Med; 2010 Jun; 21(6):1899-911. PubMed ID: 20238149
[TBL] [Abstract][Full Text] [Related]
23. Gelatin hydrogels: enhanced biocompatibility, drug release and cell viability.
Rathna GV
J Mater Sci Mater Med; 2008 Jun; 19(6):2351-8. PubMed ID: 18157687
[TBL] [Abstract][Full Text] [Related]
24. Preparation of cross-linked hyaluronic acid film using 2-chloro-1-methylpyridinium iodide or water-soluble 1-ethyl-(3,3-dimethylaminopropyl)carbodiimide.
Young JJ; Cheng KM; Tsou TL; Liu HW; Wang HJ
J Biomater Sci Polym Ed; 2004; 15(6):767-80. PubMed ID: 15255525
[TBL] [Abstract][Full Text] [Related]
25. Preparation and characterization of porous crosslinked collagenous matrices containing bioavailable chondroitin sulphate.
Pieper JS; Oosterhof A; Dijkstra PJ; Veerkamp JH; van Kuppevelt TH
Biomaterials; 1999 May; 20(9):847-58. PubMed ID: 10226711
[TBL] [Abstract][Full Text] [Related]
26. Desferrioxamine release from gelatin-based systems.
Ulubayram K; Kiziltay A; Yilmaz E; Hasirci N
Biotechnol Appl Biochem; 2005 Dec; 42(Pt 3):237-45. PubMed ID: 15984929
[TBL] [Abstract][Full Text] [Related]
27. EDC cross-linking improves skin substitute strength and stability.
Powell HM; Boyce ST
Biomaterials; 2006 Dec; 27(34):5821-7. PubMed ID: 16919327
[TBL] [Abstract][Full Text] [Related]
28. Development of D-lysine-assisted 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide/N-hydroxysuccinimide-initiated cross linking of collagen matrix for design of scaffold.
Krishnamoorthy G; Sehgal PK; Mandal AB; Sadulla S
J Biomed Mater Res A; 2013 Apr; 101(4):1173-83. PubMed ID: 23090865
[TBL] [Abstract][Full Text] [Related]
29. Carbodiimide cross-linked hyaluronic acid hydrogels as cell sheet delivery vehicles: characterization and interaction with corneal endothelial cells.
Lu PL; Lai JY; Ma DH; Hsiue GH
J Biomater Sci Polym Ed; 2008; 19(1):1-18. PubMed ID: 18177550
[TBL] [Abstract][Full Text] [Related]
30. Biodegradable microspheres: a new delivery system for growth hormone.
Di Silvio L; Gurav N; Kayser MV; Braden M; Downes S
Biomaterials; 1994 Sep; 15(11):931-6. PubMed ID: 7833443
[TBL] [Abstract][Full Text] [Related]
31. Characterization of controlled highly porous hyaluronan/gelatin cross-linking sponges for tissue engineering.
Ko CL; Tien YC; Wang JC; Chen WC
J Mech Behav Biomed Mater; 2012 Oct; 14():227-38. PubMed ID: 23122717
[TBL] [Abstract][Full Text] [Related]
32. In vivo evaluation of a biodegradable EDC/NHS-cross-linked gelatin peripheral nerve guide conduit material.
Chang JY; Lin JH; Yao CH; Chen JH; Lai TY; Chen YS
Macromol Biosci; 2007 Apr; 7(4):500-7. PubMed ID: 17429831
[TBL] [Abstract][Full Text] [Related]
33. Effect of hemostatic agents on properties of gelatin-alginate soft tissue adhesives.
Pinkas O; Zilberman M
J Biomater Sci Polym Ed; 2014; 25(6):555-73. PubMed ID: 24499482
[TBL] [Abstract][Full Text] [Related]
34. Casein/gelatin beads: I. Cross-linker solution composition effect on cross-linking degree.
Bulgarelli E; Forni F; Bernabei MT
Int J Pharm; 1999 Nov; 190(2):175-82. PubMed ID: 10547457
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and physicochemical analysis of gelatin-based hydrogels for drug carrier matrices.
Einerson NJ; Stevens KR; Kao WJ
Biomaterials; 2003 Feb; 24(3):509-23. PubMed ID: 12423606
[TBL] [Abstract][Full Text] [Related]
36. Cross-linked starch microspheres: effect of cross-linking condition on the microsphere characteristics.
Atyabi F; Manoochehri S; Moghadam SH; Dinarvand R
Arch Pharm Res; 2006 Dec; 29(12):1179-86. PubMed ID: 17225470
[TBL] [Abstract][Full Text] [Related]
37. Role of solvent-mediated carbodiimide cross-linking in fabrication of electrospun gelatin nanofibrous membranes as ophthalmic biomaterials.
Chou SF; Luo LJ; Lai JY; Ma DH
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():1145-1155. PubMed ID: 27987671
[TBL] [Abstract][Full Text] [Related]
38. Dextran cross-linked gelatin microspheres as a drug delivery system.
Cortesi R; Esposito E; Osti M; Squarzoni G; Menegatti E; Davis SS; Nastruzzi C
Eur J Pharm Biopharm; 1999 Mar; 47(2):153-60. PubMed ID: 10234540
[TBL] [Abstract][Full Text] [Related]
39. Stabilization of collagen with EDC/NHS in the presence of L-lysine: a comprehensive study.
Usha R; Sreeram KJ; Rajaram A
Colloids Surf B Biointerfaces; 2012 Feb; 90():83-90. PubMed ID: 22019452
[TBL] [Abstract][Full Text] [Related]
40. Preparation and characterization of glutaraldehyde cross-linked O-carboxymethylchitosan microspheres for controlled delivery of pazufloxacin mesilate.
Liu YF; Huang KL; Peng DM; Ding P; Li GY
Int J Biol Macromol; 2007 Jun; 41(1):87-93. PubMed ID: 17292465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
